13.10.14 : Medical News of the day... A single, brief session of resistance exercise done immediately after a visual learning task improves episodic memory by about 10%, suggests new research published in the October issue of Acta Psychologica. The US Food and Drug Administration (FDA) has approved a new antiviral drug to treat chronic hepatitis C virus (HCV) genotype 1 infections. Ledipasvir/sofosbuvir (Harvoni, Gilead Sciences) is the first combination drug for HCV as well as the first treatment that does not require administration with interferon and ribavirin. A combination of low–risk lifestyle factors substantially reduces the risk for stroke, particularly cerebral infarction, in women, according to a new study published online October 8 in Neurology. More than two decades of evidence suggests that bariatric surgery produces greater weight loss and more type 2 diabetes remissions than nonsurgical treatments for the obese, reported a review published online in JAMA Surgery. At least a dozen dietary supplements available in the US contain a potentially-dangerous synthetic stimulant that has never been tested on humans, pointed a new study. The inclusion of the stimulant known as DMBA in dietary supplements has researchers and an industry group calling on the US FDA to take action. The report is published online October 8 in Drug Testing and Analysis Cardiology : The US FDA has approved the first drug-coated balloon (DCB) for the treatment of vascular disease. The FDA approval of the Lutonix 035 paclitaxel-coated balloon (Bard) follows a unanimous vote by the agencys Circulatory System Devices panel members, all of whom voted yes to questions of safety, efficacy, and risk vs. benefit. Cardiovascular scientists at NYU Langone Medical Center have identified a protein known as Pcp4 as a regulator of the hearts rhythm. Researchers noted that when the Pcp4 gene is disrupted, it can cause ventricular arrhythmias. The findings are published online in the Journal of Clinical Investigation. Pediatrics : A first-of-its-kind study suggests that reduced attention to the human face soon after birth may increase the likelihood of being less responsive to others distress later. Study authors noted that infant facial preference and early sensitive parenting may predict development of callous, unemotional traits, which in turn might suggest a tendency toward antisocial behavior. The study was published online October 6 in Biological Psychiatry. The pneumococcal vaccine recommended for young children not only prevents illness and death, but also dramatically reduces severe antibiotic-resistant infections by 62%, suggests nationwide research presented at IDWeek 2014.
Posted on: Mon, 13 Oct 2014 03:17:26 +0000
Trending Topics
Recently Viewed Topics
© 2015